Uma revisão sobre a pesquisa genética psiquiátrica na população brasileira by Cordeiro, Quirino et al.
A review of psychiatric genetics research  
in the Brazilian population
Uma revisão sobre a pesquisa genética psiquiátrica 
na população brasileira
Correspondence
Marco Aurelio Romano-Silva
Departamento de Saúde Mental – Faculdade de Medicina
Universidade Federal de Minas Gerais
Av. Alfredo Balena, 190
30130-100 Belo Horizonte, MG, Brazil
E-mail: romanosilva@gmail.com
REVIEW
Quirino Cordeiro,1 Bruno Rezende Souza,2 Humberto Correa,2 
Camila Guindalini,3 Mara Helena Hutz,4 Homero Vallada,1 
Marco Aurélio Romano-Silva 2
1 Program of Genetics and Pharmacogenetics, Department and Institute of Psychiatry, Universidade de São Paulo (USP) Medical School, São Paulo 
(SP), Brazil
2 Department of Mental Health, Medical School, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte (MG), Brazil
3 Interdisciplinary Laboratory of Clinical Neuroscience, Department of Psychiatry, Universidade Federal de São Paulo (Unifesp), São Paulo (SP), Brazil
4  Department of Genetics, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre (RS), Brazil
Abstract
Objective and Method: A large increase in the number of Brazilian studies on psychiatric genetics has been observed in the 1970’s since 
the first publications conducted by a group of researchers in Brazil. Here we reviewed the literature and evaluated the advantages and 
difficulties of psychiatric genetic studies in the Brazilian population. Conclusion: The Brazilian population is one of the most heterogeneous 
populations in the world, formed mainly by the admixture between European, African and Native American populations. Although the 
admixture process is not a particularity of the Brazilian population, much of the history and social development in Brazil underlies the 
ethnic melting pot we observe nowadays. Such ethnical heterogeneity of the Brazilian population obviously brings some problems when 
performing genetic studies. However, the Brazilian population offers a number of particular characteristics that are of major interest 
when genetic studies are carried out, such as the presence of isolated populations. Thus, differences in the genetic profile and in the 
exposure to environmental risks may result in different interactions and pathways to psychopathology.
Descriptors: Brazil; Psychiatry; Genetic research; Population; Review
Resumo
Objetivo e Método: Desde a década de 70, quando os primeiros estudos em genética psiquiátrica conduzidos por um grupo de brasileiros 
foram publicados, o número de trabalhos realizados no Brasil vem aumentando consideravelmente. Através desta revisão, avaliamos 
as vantagens e as dificuldades da realização de pesquisas em psiquiatria genética na população brasileira. Conclusão: A população 
brasileira é uma das mais heterogêneas do mundo, formada principalmente pela combinação entre populações européia, africana e 
nativa americana. Apesar de a mistura entre raças não ser uma particularidade da população brasileira, a história e o desenvolvimento 
social no Brasil ocasionou uma grande miscigenação étnica, a qual é observada atualmente. Devido à heterogeneidade de suas origens, 
diversos problemas são levantados em estudos genéticos realizados no Brasil. Porém, a população brasileira oferece características 
particulares para desenvolvimento de pesquisas genéticas, como a presença de populações isoladas. Portanto, diferenças genéticas e 
exposição a riscos ambientais podem resultar em diferentes interações e caminhos para alterações psicopatológicas.
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Research groups and their main findings in the Brazilian 
population
The study of genetic factors related to psychiatric disorders in Brazil 
is presently growing, markedly with many different research groups 
using modern techniques to investigate diverse psychopathologies. 
However, the genetic studies started in the early 1960s when Frota-
Pessoa1,2 and Salzano3,4 published their investigations in this area. In 
the 1970s, the first Brazilian studies showing association between 
behavior and genetic components were published. Inquiring about 
behavior in twins, Salzano et al. studied several behavioral attributes 
such as intelligence and personality in monozygotic and dizygotic 
twins.5-7 In 1978, Frota-Pessoa et al. published the first Brazilian 
study showing genetic factors and a neuropsychiatric disorder, 
Huntington Chorea.8
Currently, the genomic of drug addiction is one of the fields most 
investigated in the Brazilian population. Different groups have been 
examining this subject in two different populations from the States 
of São Paulo and Rio Grande do Sul. In São Paulo, Guindalini et al., 
from the Program of Genetics and Pharmacogenetics (PROGENE) 
at the Universidade de São Paulo Medical School, have studied 
a large group of cocaine abusers and identified two positive 
associations between genetic polymorphisms and drug addiction. A 
glutathione-S-transferase (GST-Pi) functional genetic polymorphism 
(Ile105Val) was genotyped in 654 male cocaine users matched with 
572 controls, suggesting that the high activity Ile105 allele may 
influence cocaine dependence. Since dopaminergic signaling is well 
known to be related to reward system, one of the neural pathways 
involved in addition, several genetic studies have looked after targets 
in dopaminergic genes. A study found positive association with 
a dopamine transporter (DAT1) polymorphism (30-bp variable-
number tandem repeat - VNTR - in intron 8 of the gene) in 669 
cocaine users matched with 866 controls.9 In this same study, the 
authors also demonstrated that this was a functional polymorphism. 
They showed that the intron 8 VNTR3 allele has a reduction of 40% 
in reported gene expression versus the intron 8 VNTR2 allele in 
transfected SN 4741 cell-line treated with cocaine hydrochloride. 
However, investigating this same sample of patients with cocaine 
addiction, Guindalini et al. have failed to find association of 
polymorphisms of the G protein-coupled receptor kinase 3 and 
dopamine-beta hydroxylase genes with the disorder.10,11 Messas et 
al., also working with such patients, failed to find an association 
of polymorphisms of the dopamine D2 receptor (DRD2) gene TaqI 
A and dopamine D3 (DRD3) receptor gene BalI polymorphisms in 
the susceptibility to cocaine dependence.12 
Investigating alcohol dependence, Guindalini et al.13 found 
that polymorphisms of the alcohol dehydrogenase 4 gene could 
play a role in the etiology of the disorder, the same occurring 
with a polymorphism of the monoamine oxidase A (MAOA) 
gene.14 In the South region of Brazil, the Department of Genetics 
from Universidade Federal do Rio Grande do Sul (UFRGS) has 
investigated genetic factors associated with alcohol and nicotine 
dependence. Bau et al. studied if allele and genotype frequencies 
of the TaqI A polymorphism of DRD2 gene are associated with 
alcoholism.15 They found an association between this polymorphism 
not only with alcoholism but also with measures of stress and harm 
avoidance. The exon 3 VNTR at the dopamine D4 receptor (DRD4) 
gene was also associated with harm avoidance in Brazilian male 
alcoholics16 but not with alcohol dependence.17 Bau et al. described 
an interaction effect between DRD4 and DAT1 genotypes with 
novelty seeking on the level of alcohol consumption.18 In case of 
Marques et al., an association between comorbid major depressive 
disorder, drug abuse and nicotine dependence with the short allele 
of the promoter region of the serotonin transporter gene (SLC6A4) 
was suggested in a sample of 114 patients with alcohol dependence 
and 218 controls.19 Freire et al. studied a group of 100 smoking 
alcoholics, 120 non-alcoholic smokers and 112 non-smoking 
controls, and demonstrated that alcoholic and non-alcoholic smokers 
have higher frequency of the DRD2 gene TaqI A1 allele than 
non-smoking controls.20 Also, they demonstrated that individuals 
who had at least one dopamine beta-hydroxylase (DBH) 1021T 
allele smoked fewer cigarettes per day than those individuals with 
CC homozygote.21 Prestes et al. reported that alcohol dependent 
individuals with heterozygous genotype at the C825T polymorphism 
in the G-protein β3 subunit (GNB3) gene presented more frequently 
major depressive disorder than those alcohol dependent subjects 
without this genotype.22 Contini et al. reported that MAOA VNTR 
3 repeat allele was associated with alcohol dependence, an earlier 
onset of alcoholism, comorbid drug abuse among alcoholics, and 
a higher number of antisocial symptoms.23 
Another disorder that seems to be related to reward system 
disruption is pathological gambling. Thus, Sabbatini da Silva 
Lobo et al. investigated pathological gambling and found an 
association between -800 T/C polymorphism of dopaminergic 
receptor D1 (DRD1) gene and pathological gambling in a group 
of 230 patients.24 In the same group of patients, they did not find 
association with other dopamine receptors (DRD2 gene TaqIA, 
DRD3 gene Ser9Gly, DRD4 gene 48 bp exon III VNTR, DRD5 gene) 
and DAT1 gene (SCL6A3 40 bp 3’VNTR) polymorphisms. 
Schizophrenia (SCZ) and bipolar disorder (BPD) are two of the 
major psychiatric disorders most studied in Brazilian samples, and 
it is well known that both have high levels of heritability.25 Thus, 
Junqueira et al. studied some genetic factors associated with SCZ. 
Variants of four genes coding for phospholipase A2 (sPLA2, cPLA2, 
iPLA2, PAFAH), an enzymatic-complex that modulates inflammatory 
processes, were investigated in SCZ patients, and an association 
with a iPLA2 gene polymorphism in 240 SCZ patients matched 
with 312 patients was found, suggesting that iPLA2 may play a 
role in SCZ susceptibility.26 Studying again polymorphisms of PLA2 
genes, Barbosa et al. found association between BanI genotype 
and PLA2G4A activity in platelets and that the presence of the 
allele A2 may increase risk for SCZ through an increment of PLA2 
activity.27 The same group (PROGENE) investigated polymorphisms 
from dopaminergic, noradrenergic and serotonergic genes (Ser-
9-Gly DRD3 gene, VNTR DAT1 gene, 1287 A/G norepinephrine 
transporter/NET gene, G681C serotonin receptor/5-HT1Dbeta 
gene, C516T serotonin receptor/5-HT2A gene) and failed to find an 
association with SCZ.28-32 In two studies, Oliveira et al. addressed 
if a polymorphism in the promoter region of the SLC6A4 could be 
implicated in SCZ, BPD and dysthymia.33,34 However, in both studies, 
there was no difference in alleles (long/short) neither in genotypes 
frequencies between any of the groups of patients and controls. 
Meira-Lima et al. studied the same functional polymorphism of 
the SLC6A4 gene and also did not find association with BPD.35 In 
a different study, Cordeiro et al. investigated polymorphisms of the 
regulator of G-protein signaling 4 (RGS4) gene and their possible 
association with SCZ and BPD.36 271 SCZ and 306 BPD patients 
were studied in comparison with 576 controls, and there was not 
an association with SCZ and the single nucleotide polymorphisms 
(SNPs) 1, 4, 7 and 18, but they found an association with 
SNP7 and BPD. The same Brazilian sample also participated in 
a investigation with 13 independent centers studying the same 
RGS4 polymorphism, and the results of global analysis revealed 
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significant transmission distortion, suggesting overtransmission of 
two common haplotypes that account for the vast majority of all 
haplotypes.37 Meira-Lima et al. investigated a polymorphism in the 
promoter region of the tumor necrosis factor alpha (TNF-alpha) 
gene in a sample of patients with SCZ and BPD.38 The authors 
found association of such polymorphism with SCZ; however, the 
same association was not present with BPD, reinforcing the possible 
participation of the immunological system in the pathophysiology of 
SCZ. Another two studies showed genetic factors associated with BPD. 
One observed an association of the angiotensinogen polymorphism 
M235 with BPD in 115 patients matched with 323 controls.39 The 
other study, by Fridman et al., found a new non-synonymous SNP 
in the conservative domain of the arachidonate 12-lipoxygenase 
(ALOX12 gene) in BPD patients.40 It was demonstrated that the allele 
A is increased in 182 BPD patients compared to 160 control subjects. 
Passos Gregorio et al. have also been investigating the genetic factors 
associated with both SCZ and BPD.41 They reported a possible 
association of non-synonymous variants of five genes of the Notch 
pathway (NOTCH2, NOTCH3, JAGGED2, ASCL1 and NUMBL), 
which is involved in neuronal development, with SCZ in a Brazilian 
group of 200 patients and 200-paired controls and in a group of 
689 Danish patients and controls.41 When these two groups were 
merged, it was found that both 18 CAG and 18/18 CAG of NUMBL 
were associated with SCZ. Another study42 evaluated if an insertion 
of CAA in NOGO gene was associated with SCZ and BPD. There 
was no association between insertion of CAA and these psychotic 
disorders; however, that polymorphism presented a surprisingly 
predisposing distribution in different ethnic groups. Furthermore, 
to study the ancestry of this polymorphism event, the non-human 
primates Platyrrhini was investigated and the insertion was absent. 
Fridman et al. examined 182 BPD patients and 160 controls and 
showed an association between BPD and a non-synonymous SNP in 
the conservative domain of the ALOX12, which substitutes an arginine 
by a glutamine in the amino-acid position 261 (R261Q).43
Another psychiatric disorder that has been studied in the Brazilian 
population is obsessive-compulsive disorder (OCD). Meira-Lima et 
al. examined allelic and genotypic frequencies of a Val-158-Met 
substitution in the catechol-O-methyltransferase (COMT) gene, a 
44-base length variation in the regulatory region of the SLC6A4 gene 
and the T102C and C516T variants in the serotonin 5HT2A gene 
in 79 OCD patients and 202 control subjects.44 They demonstrated 
that there was a difference in genotypic distribution and allelic 
frequency for C516T 5HT2A gene polymorphism between OCD and 
controls. Miguita et al. investigated the 1287 A/G NET and VNTR 
DAT1 polymorphisms; however, they did not find an association 
with OCD.45,46 Based on the several lines of evidence supporting 
an immunologic involvement on OCD etiopathogenesis, Hounie 
et al. investigated polymorphisms of the promoter region of the 
TNF-alpha gene and association of the -308 G/A and -238 G/A 
polymorphisms with the disorder.47 The Program of the Obsessive-
Compulsive Spectrum Disorders (PROTOC) at the Universidade 
de São Paulo Medical School has conducted genetic studies on 
families. Hounie et al. found results consistent with the hypothesis 
that there is a familial relationship between OCD and rheumatic 
fever (RF), since OCD in the RF proband was found to increase the 
risk of OCD among first-degree relatives.48 In another investigation, 
Chacon et al. found that familial factors seem to contribute to specific 
OCD phenotypic components such as age at onset of obsessive-
compulsive symptoms and specific dimensions of the disorder.49
In the State of Minas Gerais, a group from Universidade Federal 
de Minas Gerais (UFMG) has been investigating genetic factors 
associated with suicidal behavior. Several studies50-52 demonstrated 
lack of genetic association between suicidal behavior and different 
polymorphisms such as A218C in tryptophan hydroxylase (TPH) 
gene, the short/long functional polymorphism in the promoter 
region of the SLC6A4 gene, and T102C in 5HT2A gene. However, 
Campi-Azevedo et al. showed an association of a polymorphism 
located in the promoter region of the SLC6A4 with suicidal behavior, 
and demonstrated that family suicidal behavior history increases 
proband suicide attempt risk.53 
An additional psychiatric disorder well studied in the Brazilian 
population is attention deficit hyperactivity disorder (ADHD). At 
UFRGS, a collaborative investigation of the departments of Psychiatry 
and Genetics is looking for genetic factors associated with ADHD. 
Roman et al. first described an association between a DRD4 exon 
3 VNTR polymorphism and ADHD in a case-control study without 
family-based analyses.54 An absence of association between the 
DAT1 3’VNTR was also described in the same investigation with 81 
families. The negative result with this polymorphism was replicated 
by Genro et al. with 243 children and adolescents and their parents; 
however, these authors observed, on family-based analyses, that 
the C allele from the -839 C > T polymorphism at the DAT1 
gene was overtransmitted to ADHD children.55 Genro et al. also 
showed that the absence of association between DRD4 and DAT1 
VNTRs polymorphisms with ADHD was not due to IQ variability.56 
Roman et al., using family-based association analyses of a 
DBH TaqI polymorphism, showed a preferential transmission 
of the A2 allele to ADHD children and adolescents.57 Roman 
et al. described an association between adrenergic alpha2A 
receptor gene (ADRA2A) -1291 C > G polymorphism with 
inattention and combined symptom scores.58 This finding was 
further replicated in an independent sample of ADHD children 
and adolescents from the same population.59 Schmitz et al. 
showed, in a case control study with a sample of 100 ADHD 
children and 100 non-ADHD children, an association between 
ADHD inattentive type and this ADRA2A gene polymorphism.60 
Guimaraes et al. found, in a sample of 243 ADHD children, 
that the polymorphism His452 allele of the 5HT2A gene may be 
associated with ADHD in boys, but not in girls, which suggests a 
gender effect on the genetic susceptibility to the disorder. In the 
same group of patients, these authors did not find association 
with a SLC6A4 gene polymorphism.61 Szobot et al., using 
single photon emission computed tomography (SPECT) during 
continuous performance test, observed a significantly higher 
perfusion in the right middle temporal gyrus in the ADHD group 
with risk alleles at both DRD4 and DAT1 loci, when compared 
to ADHD boys without risk alleles at both loci.62 These findings 
suggested that a higher recruitment in middle temporal gyrus, an 
area associated with working memory and selective attention, 
should exist to compensate a putative effect of the interaction 
between these dopaminergic genes. Another study by Rhode et 
al., comparing cerebral blood flow assessed by SPECT from two 
groups of four ADHD children, showed that the group presenting 
homozygosity for the 10-repeat allele at DAT1 gene has higher 
blood flows in medial frontal and left basal ganglia areas, compared 
to children without this genotype.63 Kieling et al. evaluated the 
association between the exon 3 VNTR in the DRD4 gene and 
the performance of children and adolescents with ADHD in a 
continuous performance test (CPT).64 The presence of a 7-repeat 
allele was associated with more errors of commission and the 
homozygosity of the 4-repeat allele was related to fewer errors of 
commission and omission even after adjusting for age. 
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Recently, many studies have been demonstrating that genetic 
variations are associated with differences in pharmacological 
treatment response. Thus, several studies conducted by the group 
from UFRGS also described a pharmacogenetic component for ADHD 
clinical response to methylphenidate (MPH) treatment. In one of their 
studies, Polanczyk et al. demonstrated an association between the 
ADRA2A gene -1291 C > G polymorphism and clinical response to 
3-month MPH treatment in children and adolescents with ADHD, 
showing that the improvement of inattentive symptoms is higher in 
G allele carriers.65 A study from Roman et al. with 50 male ADHD 
youths treated with MPH showed that 10-repeat allele at DAT is 
associated with poor response to the drug.66 However, Zeni et al. 
showed, in 111 patients, a lack of association between response 
and side effects to 1-month MPH treatment and polymorphisms 
in dopaminergic DRD4 and DAT1 genes and serotonergic genes 
(HTR1B, HTR2A and 5–HTT).67 The PROGENE group has also 
performed studies in the field of pharmacogenetics. Cordeiro et al. did 
not find support for the hypothesis that the Ser9Gly polymorphism of 
the DRD3 gene influences the response to typical antipsychotics.68 In 
another study, Michelon et al. found that the polymorphisms of the 
SLC6A4, glycogen synthase kinase-3beta, inositol polyphosphatase 
1-phosphate, brain-derived neurotrophic factor and activator protein 
2beta genes are not predictive factors for lithium prophylactic response 
in a sample of BPD type I patients.69
Challenges for the improvement of psychiatric genetic studies 
in Brazil
1. Financial support
Despite of the development of investigations on psychiatric genetics 
in Brazil, the researchers have faced some important challenges. 
Research grants are highly competitive since they are mainly provided 
by government sources. Some States, such as São Paulo, have 
developed a strong research granting system, permitting a stable 
financial situation. In recent years, the Brazilian Federal Government 
has been able to sustain a continuously low however constant level 
of funding. The main source of support comes from the National 
Council of Scientific and Technological Development (CNPq) and 
the Financing Council for Studies and Projects (FINEP).70 Between 
2000 and 2004, the public sector (Federal and State funds) was 
responsible for supporting an average of 57% of the investments in 
research and development (R&D) in the country. The percentage of 
investments by the private sector is almost entirely used by private 
companies with negligible funding in universities (public or private). 
During the same period, the total investment in R&D in Brazil had 
an average of 1.32% of the Gross Internal Product, in contrast with 
other countries such as Canada (33.7%), France (37.6%), Germany 
(30.4%), Japan (18.1%), the UK (32.8%) and the USA (31%).71 
In an attempt to overcome the problem regarding funding for 
research, Brazilian researchers have tried to obtain grants from 
international institutions, which have been used to buy laboratory 
materials and equipment, and training human resources. Another 
possible alternative for dealing with lack of funding has been 
the establishment of collaborative projects with different groups 
around the world.72,73 International collaboration has been based 
on contacts during doctoral, post-doctoral or sabbatical training 
of Brazilian researchers, mainly in laboratories of North America, 
Europe, Australia and Japan. 
2. Ethnic characteristics of the Brazilian population
Psychiatric genetic research in Brazil is further complicated by 
another important issue derived from the ethnic admixture of the 
population, especially when conducting unrelated case-control 
design, the simplest and one of the most powerful forms of genetic 
association investigations. 
The Brazilian population is one of the most heterogeneous 
populations in the world, formed mainly by the admixture between 
European, African and Native American populations. Although the 
admixture process is not a particularity of the Brazilian population, 
since it is also present in many other American countries such as 
Mexico and the United States, the ethnic melting pot we observe 
nowadays is underlain by the history and social development in 
Brazil.
 Briefly, the European colonization of Brazil was initially made 
by the Portuguese. About 500,000 of them (almost exclusively 
men) arrived in Brazil between the years of 1500 and 1800. They 
met the Amerindians, which were estimated in 2.4 million by the 
year 1500, and about 4 million Africans who were compulsorily 
introduced in Brazil as slaves until the mid 18th century. From early 
18th century until 1975, a new wave of migration was observed. 
During that period about 6 million official migrants came to Brazil 
from different countries, but mainly from Italy, Portugal, Spain, 
Germany, Syria, Lebanon and Japan. A review about the ethnic 
admixture in Brazilian and other Latin American populations was 
recently published by Salzano & Bortolini.74 
The present Brazilian population is the result of centuries of 
multiethnic crossings between Amerindian, African and European 
people. Due to different patterns of distribution of immigrants and 
the continental size of the country, several authors have observed 
a great heterogeneity in the ancestry of the Brazilian populations, 
using different markers.75 Santos and Guerreiro estimated levels of 
Amerindian admixture higher than 41% in the Brazilian northern 
region. In this region, the European and African contributions 
were of 47% and 12%, respectively.76 On the other hand, in the 
southernmost State of Rio Grande do Sul, the overall admixture 
analysis showed again a pattern of European > Amerindian > 
African contribution, but the levels of admixture showed a vast 
majority (82%) of European ancestry, the degree of African and 
Native American admixture were 7% and 11% only.77 In addition, 
a strong directional mating leading to an ethnic-related gender 
bias in the formation of our population was also demonstrated. 
Studies carried out with Brazilians classified as White have 
showed that their matrilineal ancestry evaluated by mitochondrial 
DNA haplogroups exhibits a rather equilibrate contribution among 
Amerindian, Europeans and African ancestries,78 whereas the 
vast majority of Y chromosomes in white Brazilian males are of 
European origin (97.5%), with a surprisingly low frequency of 
African chromosomes (2.5%) and a complete absence of Native 
American contributions,79 suggesting a preferential mating between 
European males and African and Amerindian females. However, a 
recent investigation with a larger sample size reported a different 
picture for this scenario.80 Y-chromosome admixture estimates 
obtained from southern Brazilians showed 92% European, 5% 
African, and 3% Native American contributions indicating that, 
despite the high percentage of the European participation, there is 
a non-negligible African and a residual Amerindian contribution of 
Y chromosomes to this population as well. 
Such ethnical heterogeneity of the Brazilian population, as 
mentioned above, obviously brings some problems when performing 
genetic studies, particularly case-control associations.81 The basic 
idea behind this design is to localize markers loci at which alleles 
or genotypes are more frequent among cases than controls. An 
association between alleles or genotypes of the investigated marker 
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and phenotype is to imply linkage disequilibrium (LD) between this 
marker and a disease locus. This holds true only for a random-
mating population, in which LD decays quite rapidly with distance 
and only close related markers will remain together. 
Since both, diseases and allele frequencies are known to vary 
significantly among populations, conducting genetic association 
studies in admixed samples may be confounded if the differences in 
allele frequencies between cases and controls are due to systematic 
differences in ancestry rather than association of genes with the 
phenotype of interest. 
It is argued that admixture-matched case-control strategies can 
efficiently control population stratification,82 particularly collecting 
as much information about ethnicity as possible, in order to provide 
an accurate ethnic stratification and reduce false-positive results. 
However, this view is not consensual83 and, particularly in Brazil, 
it has been demonstrated that physical appearance or self-reported 
background are not efficient predictors of genomic ancestrality.84 
Nevertheless, Zembrzuski et al.,85 using the same markers and the 
same methodology described by Parra et al.,84 demonstrated that, 
at least for the southern Brazilian population, physical appearance 
was strongly correlated with admixture estimates. 
In order to overcome the problem of population stratification some 
alternatives have been proposed and used by Brazilian researchers, 
such as family-based designs. The most popular method involves 
the use of nuclear families (two parents and one affected offspring) 
and the employment of transmission disequilibrium test (TDT).86 In 
this type of design, distortions in allele transmission are investigated, 
comparing the frequency of the parental alleles that were transmitted 
to affected children and those not transmitted. Thus, any difference 
in the allele frequency observed in the population level becomes 
irrelevant, since the cases are the transmitted alleles and controls, 
the not transmitted ones, within the family. This has been the main 
method used for ADHD studies by the group from Universidade 
Federal do Rio Grande do Sul; however, this method may not be 
feasible for diseases of late onset in the Brazilian population. Another 
possibility to avoid stratification is to use more homogenous samples, 
such as the ones living in the State of Rio Grande do Sul, south 
of Brazil, a place that has received an important recent European 
migration, and has suffered less African and Native American 
influence.87 Zembrzuski et al. reported an absence of population 
stratification for those southern Brazilians classified as of European 
descent based on skin color and physical characteristics.88 
In addition, recently, some investigators have begun to suggest 
quantitative methods with the promise of detecting population 
stratification and even correcting for it when it is present in a sample 
of unrelated individuals.89-91 Each of these proposed methods 
requires the genotyping of extra polymorphic markers not associated 
with the candidate loci, referred as unlinked markers, to detect 
this “signatures” and correct the statistical test for the presence 
of stratification. A method named Genomic Control92 has been 
evaluated in a number of studies examining genetic associations in 
different populations.93,94 Genomic Control examines the chi-square 
distribution between unlinked markers in case and controls, which, 
in the presence of stratification, should be inflated by a certain value. 
This value can be estimated and a multiplier is derived to adjust the 
critical value for significance tests for the candidate loci.92 On the 
other hand, other authors suggest the use of unlinked genotypes to 
assign individuals to subpopulations and to test for the candidate 
loci association upon population membership, assuming that 
within each subpopulation there is Hardy-Weinberg equilibrium, 
and linkage equilibrium between all markers. Zembrzuski et al. 
proposed the use of an index derived from ancestry informative 
markers to estimate admixture at the individual level in order to 
control for population stratification by removing samples from 
cases or controls.86 They have shown that it is possible to control 
for population stratification by choosing individuals without the 
loss of statistical power as occurs with the use of other methods 
of genomic control. 
A recent developed program, named ADMIXMAP, has been 
applied for modeling admixture in the Brazilian sample. ADMIXMAP 
uses ancestry informative genetic markers to model admixture in a 
population formed by two or more founding populations. If individual 
admixture is estimated, it is possible to investigate the relationship 
between admixture and disease risk and to control for the confounder 
admixture proportions in genetic associations studies by modeling 
its effect on the analysis.9
The context of psychiatric genetic studies in Brazil
1. Brazilian sociodemographic characteristics
The Brazilian population offers a number of particular 
characteristics that are of major interest when genetic studies are 
carried out, such as the presence of isolated populations. Brazil 
has a large territory and until recently many regions had not been 
explored or populated yet. This situation allowed some groups 
(generally the ones escaping Portuguese domination) to establish 
small communities; with few numbers of settlers that remained 
isolated for generations. In recent years, a number of studies were 
conducted, showing that many of these populations exhibit a high 
inbreeding coefficient and an important role of genetic drift.95,96 In 
those conditions, the total gene pool and number of different genes 
involved in a trait is limited and complex traits are expected to be 
more homogeneous, increasing the chance of success of a genetic 
association study. 
It is important to note that the pathways to mental disorders in 
populations from developing countries are not necessarily the same 
as they are in populations from developed countries. Differences in 
the genetic profile and in the environmental risks exposure frequency 
and intensity may result in different interactions and trajectories to 
psychopathology. In Brazil, as in the other Latin American countries, 
most children are exposed to a number of adverse events associated 
with mental disorders such as poverty, family disruption, drug traffic, 
and urban violence. 
Also of great interest is that Brazil has experienced until the 1980’s 
an explosive population growth that led population from 40 million 
inhabitants by 1940 to 180 million in the year 2004. Much of this 
increase was due to high fertility combined with declining mortality 
rates. In other words, between the 1940’s and the 1980’s, each 
Brazilian woman had an average of 6 children (this has declined to 
2.3 in the 2000’s), illustrating that Brazilian families are still rather 
numerous97 and family-based genetic studies have a great potential 
of success. In addition to that, probably due to catholic religious 
practice, Brazil has one of the lowest divorce rates in the world (an 
average of about 1.2 per 1,000 inhabitants per year in contrast 
with a 4.9 rate in the United States),98 suggesting that accessing 
individuals for the investigations may be facilitated, especially if 
the low mobility and the high acceptance to participate in scientific 
studies of the Brazilian population is taken into account.
2. Psychiatric disorders with higher prevalence in Brazil
Another interesting issue to be considered is the possibility of 
conducting genetic studies on psychiatric phenotypes that have high 
prevalence in Brazil. Vallada et al. have collected a large sample 
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of over 700 cocaine addicts and have been conducting a number 
of association studies, investigating candidate genes for cocaine 
addiction, a condition highly prevalent in the country.99
3. Translation of assessment scales into Portuguese
The development of psychiatric genetic research in Brazil 
needs to be followed by an accurate translation to Portuguese of 
diagnostic instruments and questionnaires mostly used in the area, 
such as the “Diagnostic Interview for Genetic Studies” (DIGS)100 
and the “Operational Criteria” (OPCRIT).101 This will facilitate 
comparison and discussion of the findings and collaboration with 
international centers of research, improving scientific methods and 
providing correct assessments of the phenotype, an essential issue 
when conducting genetic studies.
4. Bioethics development
Genetic research presents a long-term possibility of tailoring to 
specific subpopulations of patients. This will improve diagnosis 
and therapeutic efficiency and will minimize the adverse effects 
of drugs, increasing their safety and tolerability and reducing 
health costs. Undoubtedly, ethical dilemmas come from the 
development and use of new technologies. This does not mean 
that science must be under strict judgment, but the moral limits 
accepted as valid on science progression, as well as its control, 
must be dictated by society. Therefore, it is imperative, when 
considering the cost-benefit of a specific technology, to be sure 
that the target population will not become vulnerable. Although 
bioethics in Brazil can be considered a “late bioethics”, since it 
started in the last decade, it can be said that Brazil has had quick 
and visible advances in the area of research involving human 
subjects. In 1996, it became compulsory (Bill 196/96) to have 
ethical clearance for research involving human beings. This bill 
has created local Ethics Committees (CEPs) linked to the National 
Commission of Ethics in Research (CONEP). Today there are 
more than 527 CEPs, showing the rapid expansion of this matter. 
Following the Bill 196/96, other similar bills were introduced 
throughout Brazil, such as the Federal Law 8.974, from 5th 
January 1995, dealing with the use of genetic techniques and 
genetically modified organisms.
Conclusion
In conclusion, despite the problems that, in general, the 
Brazilian researchers have faced in terms of financial support 
and methodological issues, there are tremendous efforts to 
overcome these limitations and to conduct and maintain 
scientific projects with the highest degree of quality and ethical 
commitment. In addition, not only the psychiatric genetic 
research but also the genetic research in particular could be 
more productive, considering a country of the size of Brazil. 
Moreover, the geography and socioeconomic characteristics 
of Brazil, together with the particular genetic constitution of 
the Brazilian population, also present some features that may 
be interesting for the development and success of psychiatric 
genetic studies in the country.
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